Where does OtoNexus Medical Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), OtoNexus Medical Technologies, Inc. ranks #14,837 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does OtoNexus Medical Technologies, Inc. hold?

OtoNexus Medical Technologies, Inc. holds 20 US utility patents granted between 2019 and 2025, spanning 13 technology areas.

What is OtoNexus Medical Technologies, Inc.'s Innovation Score?

OtoNexus Medical Technologies, Inc. has an Innovation Score of 57.2 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does OtoNexus Medical Technologies, Inc. focus on?

OtoNexus Medical Technologies, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 19 patents, ranking #930 of 7,127 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is OtoNexus Medical Technologies, Inc.'s patent grant rate increasing or decreasing?

OtoNexus Medical Technologies, Inc.'s recent grant velocity is +1600% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for OtoNexus Medical Technologies, Inc.'s patents?

OtoNexus Medical Technologies, Inc.'s patents average 23.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the OtoNexus Medical Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

OtoNexus Medical Technologies, Inc.

USPTO PatentsView assignee record - 20 granted patents across 13 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Otonexus ranks #14,837 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 13 technology areas.

#14,837
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.2/100): 23.2
avg claims per patent: +1600%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14837 · US Corporation #14,837 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,837/49,997
PHOTO-FINISH Omega (Omega )(Omega )
CPC-FOCUS A61B · 13 areas
INNOV-PAR 57.2/100
CLAIMS-DENSE 23.2 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +1600% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Omega SA (Omega AG)(Omega Ltd.) (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Otonexus’s 57.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (18%) Velocity 20.0 pts (35%) Breadth 12.7 pts (22%) Claim depth 13.9 pts (24%)

Qualcomm Incorporated · highest

85
OtoNexus Medical · this assignee

57
3D Lighting… · lowest

7

What this shows Otonexus's Innovation Score is 57.2/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Otonexus?

Each dot is one of Otonexus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Otonexus’s own 23.2 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Otonexus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Otonexus's grants concentrate

OtoNexus Medical Technologies, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 95% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (6 grants) versus a trough of 1 in 2019. By volume, Otonexus sits between Omega SA (Omega AG)(Omega Ltd.) and Palfinger AG.

Otonexus's three-year grant acceleration

OtoNexus Medical Technologies, Inc. shows 14 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Omega (Omega )(Om…

20
Oneida Air Systems

20
Optovate

20
Ostomycure AS

20
Otsuka Medical De…

20
Owl biomedical

20
Paion UK

20
Palfinger

20
Otonexus Medical ◀

20

What this shows OtoNexus holds 20 patents at rank #14,834, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near OtoNexus

By rank, the assignees closest to #14,834 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in OtoNexus's primary technology class.

Otonexus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

OtoNexus Medical Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	5.0%
2020	3	15.0%
2022	3	15.0%
2023	5	25.0%
2024	6	30.0%
2025partial year	2	10.0%

Which technologies does OtoNexus Medical Technologies, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 19

B06B - Methods OR Apparatus FOR Generating OR Transmitting Mechanical Vibrations OF Infrasonic, Sonic, OR Ultrasonic Frequency, ; e.g.; FOR Performing Mechanical Work IN General 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

G06V - Image OR Video Recognition OR Understanding 2

G06F - Electric Digital Data Processing 2

G06N - Computing Arrangements Based ON Specific Computational Models 2

G06T - Image Data Processing OR Generation, IN General 2

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 2

G02B - Optical Elements, Systems OR Apparatus 2

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 2

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

OtoNexus Medical Technologies, Inc.'s patent record in context - here's where to go next.

OtoNexus Medical Technologies, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 95% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #14,837 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare OtoNexus Medical Technologies, Inc. against Omega SA (Omega AG)(Omega Ltd.), an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.